BlackRock’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60M | Buy |
|
|||||
|
2025
Q1 | $57.6M | Buy |
|
|||||
|
2024
Q4 | $79.1M | Buy |
|
|||||
|
2024
Q3 | $78.3M | Buy |
|
|||||
|
2024
Q2 | $56.5M | Buy |
|
|||||
|
2024
Q1 | $21.1M | Buy |
|
|||||
|
2023
Q4 | $425K | Sell |
|
|||||
|
2023
Q3 | $242K | Sell |
|
|||||
|
2023
Q2 | $238K | Sell |
|
|||||
|
2023
Q1 | $188K | Buy |
|
|||||
|
2022
Q4 | $291K | Sell |
|
|||||
|
2022
Q3 | $542K | Sell |
|
|||||
|
2022
Q2 | $540K | Sell |
|
|||||
|
2022
Q1 | $6.72M | Sell |
|
|||||
|
2021
Q4 | $14.2M | Buy |
|
|||||
|
2021
Q3 | $23.7M | Sell |
|
|||||
|
2021
Q2 | $21.6M | Sell |
|
|||||
|
2021
Q1 | $26.5M | Buy |
|
|||||
|
2020
Q4 | $25.5M | Buy |
|
|||||
|
2020
Q3 | $22.2M | Sell |
|
|||||
|
2020
Q2 | $29.8M | Buy |
|
|||||
|
2020
Q1 | $8.9M | Sell |
|
|||||
|
2019
Q4 | $14.7M | Buy |
|
|||||
|
2019
Q3 | $14.6M | Buy |
|
|||||
|
2019
Q2 | $12.7M | Buy |
|
|||||
|
2019
Q1 | $12M | Buy |
|
|||||
|
2018
Q4 | $9.77M | Buy |
|
|||||
|
2018
Q3 | $9.85M | Buy |
|
|||||
|
2018
Q2 | $8.7M | Buy |
|
|||||
|
2018
Q1 | $243K | Buy |
|
|||||
|
2017
Q4 | $119K | Buy |
|
|||||
|
2017
Q3 | $91K | Sell |
|
|||||
|
2017
Q2 | $72K | Buy |
|
|||||
|
2017
Q1 | $113K | Buy |
|